A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers

Exclusion Criteria

• •1. More than two products of 15 cm x15 cm needed to cover the whole wound and affected peri-wound area
• •2. Wound cavity and/or fistula
• •3. Full thickness burns
• •4. Exposed tendons and/or fascia
• •5. Bleeding wounds
• •6. Malignant or fungating wounds
• •7. Wound age \> 12 months
• •8. Use of antimicrobial dressings or topical agents such as antiseptics, local antibiotics and steroids within 7 days from inclusion on the wound intended to be included
• •9. Untreated limb ischemia (according to investigator's judgement) at the time of inclusion
• •10. Subject not suitable for the investigation according to the investigator's judgement
• •11. Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
• •12. Known allergy/hypersensitivity to any of the components of the primary dressing